{"nct_id":"NCT02556892","title":"A Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Treatment-naive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma","status":"COMPLETED","status_verified_date":"2019-07","start_date":"2015-07-03","start_date_type":"ACTUAL","primary_completion_date":"2018-08-20","primary_completion_date_type":"ACTUAL","completion_date":"2018-08-20","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["JNJ"]}